Charles River Laboratories International is a diagnostic & research company located in Massachusetts, United States, which is part of the Healthcare sector, and is traded under the ticker CRL on the NYSE exchange.
Charles River Laboratories International stock last closed at $201.82, up 1.91% from the previous day, and has decreased 28.93% in one year. It has underperformed other stocks in the Diagnostics & Research industry by 0.18 percentage points. Charles River Laboratories International stock is currently +11.28% from its 52-week low of $181.36, and -34.51% from its 52-week high of $308.15.
There are currently 50.99M shares of CRL outstanding. The market value of CRL is $10.29B. In the past 24 hours, 465,658 CRL shares were traded.
You will need an online brokerage account to access the NYSE market and buy CRL stock.
We believe that eToro is the best online stock brokerage. eToro gives you:
Get $10 towards your purchase of shares by signing up for an account with eToro now.
Open eToro AccountNow that you've selected the right brokerage, the next step is to fill out some personal details so you are able to invest in CRL today.
Now that you've opened your account on the highest rated stock app, you need to deposit funds:
Watch the tutorial below to see the process of transferring funds into your investment account.
Once you have figured out the best place to buy Charles River Laboratories International stock, it's important to analyze their stock prior to buying, so you actually comprehend the risk and opportunity.
WallStreetZen was designed to help average investors do more accurate fundamental analysis.
You can view all of the due diligence checks on CRL's stock page.
You can use a variety of different financial metrics, analyses, models, and charts to gauge CRL's true value.
Using relative valuations measures:
You can access more valuation research on CRL's stock here.
Out of 7 sell side analysts who track CRL, the consensus analyst rating on Charles River Laboratories International is a Buy
It's important to keep in mind that analyst ratings are not stock recommendations, nor are they financial advice.
David Windley, a top 6% analyst from Jefferies maintains CRL with a hold rating and lowers their CRL price target from $233.00 to $203.00, on Mar 28, 2023.
Dan Leonard, a top 7% analyst from Credit Suisse maintains CRL with a buy rating and lowers their CRL price target from $280.00 to $260.00, on Feb 23, 2023.
Ricky Goldwasser, a top 4% analyst from Morgan Stanley maintains CRL with a hold rating and lowers their CRL price target from $241.00 to $230.00, on Feb 23, 2023.
Patrick B Donnelly, a top 6% analyst from Citigroup maintains CRL with a strong buy rating and lowers their CRL price target from $280.00 to $260.00, on Feb 23, 2023.
Sandy Draper, a top 9% analyst from Guggenheim upgrades CRL to a strong buy rating and announces their CRL price target of $255.00, on Feb 23, 2023.
You can dive deeper into what analysts are saying on the Charles River Laboratories International stock forecast page.
Last year, CRL earnings were $486.23M. In the past 5 year, CRL's earnings have grown by 29.77% per year. This was faster than the Diagnostics & Research industry average of 27.63%.
Last year, CRL revenue was $3.98B. During the last 5 year, CRL's revenue has gone up by 16.44% per year. This was faster than the Diagnostics & Research industry average of 16.32%.
Dive into CRL's earnings and revenue performance here.
In the last 12 months, executives and large shareholders at CRL have sold more shares than they have bought.
Richard F. Wallman, Director of CRL, was the latest CRL insider to buy. They bought $386,277.50 worth of CRL stock on Feb 23, 2023.
Dig into more about who owns CRL shares here.
No, Charles River Laboratories International doesn't provide an income stream by paying out dividends.
One of the major reasons eToro is our favorite brokerage is because of its social trading community.
Click below to learn what other investors have to say.
You have two main options:
Click the Open button and eToro will place the order.
If you require additional help investing in stocks on eToro, click the how to video below:
Now that you own some CRL shares, you'll want to stay up-to-date on your new investment.
Create a watchlist to keep tabs on your CRL stock.
To reiterate, here are the 6 steps to buy Charles River Laboratories International stock:
If you require a online brokerage, eToro is our recommended option.
Get Started with eToro TodayIf you want to keep tabs on your investment in Charles River Laboratories International, click below.